New Treatment for Nocturnal Enuresis in Children
Recruiting
N/A
Interventional Study
Nocturnal Enuresis in Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 6 – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 450 (estimated)
- Sponsor
- Sohag University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age : 6 - 18 years old.
* All children diagnosed by Primary monosymptomatic nocturnal enuresis in this age group.
Exclusion Criteria:
* Secondary nocturnal enuresis (child who has been continent for at least 6 months before the onset of bedwetting ).
* congenital anomalies (…
Contacts